The active content has been identified as the N-terminal acetylated 17-23 fragment of Thymosin Beta-4 (Ac-LKKTETQ)
Key handling errors that can cause problems include: Shaking the vial vigorously during reconstitution, which denatures the peptide Using sterile water instead of bacteriostatic water, which lacks preservatives and allows bacterial growth Storing reconstituted peptide at room temperature instead of refrigerated Leaving the vial exposed to light, which degrades photosensitive amino acids Using reconstituted peptide beyond its stability window, typically 3-4 weeks Properly handled AOD 9604 should be clear and colorless in solution
2,3 Correction of deficiency different routes of administration Depending on the cause of the deficiency, different strategies to correct it can be applied, although in conventional medical practice the most common treatment is intramuscular (i.m.) injection of B12
Use telehealth providers instead of brick-and-mortar clinics, commit to multi-month plans for discounts, start with single peptides before adding complexity, cycle peptides appropriately rather than continuous use, and verify you're paying for legitimate compounded peptides rather than premium pricing without justification
